| Unique ID issued by UMIN | UMIN000061264 |
|---|---|
| Receipt number | R000069873 |
| Scientific Title | A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan. |
| Date of disclosure of the study information | 2026/04/16 |
| Last modified on | 2026/04/15 09:32:26 |
A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.
A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.
A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.
A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.
| Japan |
MCI due to Alzheimer's disease (AD) or Mild AD dementia
| Adult |
Others
NO
The objective of this study is to quantify the factors and preferences influencing treatment selection for mild cognitive impairment and mild dementia due to Alzheimer's disease, expressed as utility values derived from the value judgments of the general population.
Others
Treatment Preferences Study
Utility values represent the factors and preferences underlying treatment selection for mild cognitive impairment and mild dementia due to Alzheimer's disease in the general population.
Observational
| 40 | years-old | <= |
| 80 | years-old | > |
Male and Female
Participants must meet all of the following conditions to be eligible for inclusion in the study:
1. Aged 40 years or older and younger than 80 years at the time of enrollment.
2. Provides informed consent to participate in the study.
3. Resides in Japan at the time of enrollment.
4. Has access to the necessary devices and a stable internet environment to complete the study online.
Participants who meet any of the following conditions will be excluded from the study:
1. Individuals for whom obtaining informed consent or completing the study procedures is deemed difficult due to insufficient comprehension ability, cognitive capacity, or Japanese language proficiency.
2. Individuals who are unable to personally participate in the survey.
2000
| 1st name | Kiyoyuki |
| Middle name | |
| Last name | Tomita |
Eisai Co., Ltd.
Japan Value and Access Department
112-8088
Koishikawa 4-6-10, Bunkyo-ku, Tokyo, 112-8088, Japan
080-2158-5462
k2-tomita@hhc.eisai.co.jp
| 1st name | Mie |
| Middle name | |
| Last name | Azuma |
Eisai Co., Ltd.
Japan Value and Access Department
112-8088
Koishikawa 4-6-10, Bunkyo-ku, Tokyo, 112-8088, Japan
070-2474-2454
m3-azuma@hhc.eisai.co.jp
Eisai Co., Ltd.
Eisai Co., Ltd.
Profit organization
Japan
Shiba Palace Clinic IRB
Daiwa A Hamamatsu-chiyou building, 6 floor, 1-9-10 Hamamatsu-chiyou, Minato-ku, 105-0013 Tokyo
03-5408-1555
rinri@s-palace-clinic.com
YES
R2000-J081-016
Eisai Co., Ltd.
| 2026 | Year | 04 | Month | 16 | Day |
Unpublished
Preinitiation
| 2026 | Year | 04 | Month | 09 | Day |
| 2026 | Year | 04 | Month | 09 | Day |
| 2026 | Year | 04 | Month | 20 | Day |
| 2026 | Year | 05 | Month | 31 | Day |
This study is classified, in accordance with the Ethical Guidelines for Life Science and Medical Research Involving Human Subjects, as a non-invasive, non-interventional research study that does not use human-derived biological specimens, and is conducted as an online questionnaire survey targeting members of the general public.
The survey will be carried out via the internet between April and May 2026.
To evaluate treatment-related attributes and preferences, the study employs a Discrete Choice Experiment (DCE) method, which enables quantitative estimation of respondents' latent preferences.
| 2026 | Year | 04 | Month | 15 | Day |
| 2026 | Year | 04 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069873